Cargando…
Head-to-Head Comparison of 5 Anti-SARS-CoV-2 Assays Performance in One Hundred COVID-19 Vaccinees, over an 8-Month Course
The immunoassays used to measure anti-spike SARS-CoV-2 antibodies are widely available on the market. However, their performance in COVID-19 vaccinees is not yet adequately assessed. Our study provides a head-to-head comparison of five methods: Abbott’s S1-RBD IgG, Roche’s S1-RBD total antibody, Eur...
Autores principales: | Swadźba, Jakub, Anyszek, Tomasz, Panek, Andrzej, Chojęta, Agnieszka, Wyrzykowska, Kinga, Martin, Emilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221713/ https://www.ncbi.nlm.nih.gov/pubmed/35741236 http://dx.doi.org/10.3390/diagnostics12061426 |
Ejemplares similares
-
Anti-Spike SARS-CoV-2 IgG Assessment with a Commercial Assay during a 4-Month Course after COVID-19 Vaccination
por: Swadźba, Jakub, et al.
Publicado: (2021) -
The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
por: Swadźba, Jakub, et al.
Publicado: (2023) -
The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2021) -
A comparison of 7 commercial anti-SARS-CoV-2 antibody immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2020) -
Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)